{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:06:52Z","timestamp":1779109612167,"version":"3.51.4"},"publisher-location":"Berlin, Heidelberg","reference-count":190,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2026_343","type":"book-chapter","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:14:11Z","timestamp":1779106451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolution Pharmacology Targeting the Melanocortin System"],"prefix":"10.1007","author":[{"given":"Nicholas J.","family":"Day","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla S. A.","family":"Davan-Wetton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Khodeneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed T.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinidad","family":"Montero-Melendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"343_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1021\/ml5005365","volume":"6","author":"AF Abdel-Magid","year":"2015","unstructured":"Abdel-Magid AF (2015) Allosteric modulators: an emerging concept in drug discovery. ACS Med Chem Lett 6:104\u2013107","journal-title":"ACS Med Chem Lett"},{"key":"343_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.msard.2017.03.004","volume":"15","author":"A Akcali","year":"2017","unstructured":"Akcali A, Zengin F, Aksoy SN, Zengin O (2017) Fatigue in multiple sclerosis: is it related to cytokines and hypothalamic-pituitary-adrenal Axis? Mult Scler Relat Disord 15:37\u201341","journal-title":"Mult Scler Relat Disord"},{"key":"343_CR3","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1021\/jm00132a010","volume":"32","author":"F Al-Obeidi","year":"1989","unstructured":"Al-Obeidi F, Castrucci AM, Hadley ME, Hruby VJ (1989) Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem 32:2555\u20132561","journal-title":"J Med Chem"},{"key":"343_CR4","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1111\/bph.17322","volume":"181","author":"PRJ Almeida","year":"2024","unstructured":"Almeida PRJ, Periard AM, Tana FL, Avila RE, Milhorato LB, Alcantara KMM, Resende CB, Serufo AV, Santos FR, Teixeira DC, Queiroz-Junior CM, Fonseca TCM, Silva BLV, Costa VV, Souza RP, Perretti M, Jonassen TEN, Teixeira MM (2024) Effects of a pro-resolving drug in Covid-19: preclinical studies to a randomized, placebo-controlled, phase Ib\/IIa trial in hospitalized patients. Br J Pharmacol 181:4750\u20134765","journal-title":"Br J Pharmacol"},{"key":"343_CR5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110571","volume":"301","author":"J Argerich","year":"2025","unstructured":"Argerich J, Munoz-Reyes D, Val-Garcia ID, Garcia-Nafria J (2025) Constitutively active orphan G protein-coupled receptors through the lenses of cryo-electron microscopy. J Biol Chem 301:110571","journal-title":"J Biol Chem"},{"key":"343_CR6","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/sj.jid.5700318","volume":"126","author":"M Artuc","year":"2006","unstructured":"Artuc M, Bohm M, Grutzkau A, Smorodchenko A, Zuberbier T, Luger T, Henz BM (2006) Human mast cells in the neurohormonal network: expression of Pomc, detection of precursor proteases, and evidence for Ige-dependent secretion of alpha-Msh. J Invest Dermatol 126:1976\u20131981","journal-title":"J Invest Dermatol"},{"key":"343_CR7","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","volume":"103","author":"KL Ayers","year":"2018","unstructured":"Ayers KL, Glicksberg BS, Garfield AS, Longerich S, White JA, Yang P, Du L, Chittenden TW, Gulcher JR, Roy S, Fiedorek F, Gottesdiener K, Cohen S, North KE, Schadt EE, Li SD, Chen R, Van Der Ploeg LHT (2018) Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at Mc4r agonist treatment. J Clin Endocrinol Metab 103:2601\u20132612","journal-title":"J Clin Endocrinol Metab"},{"key":"343_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1081\/ERC-120016798","volume":"28","author":"AH Baig","year":"2002","unstructured":"Baig AH, Swords FM, Szaszak M, King PJ, Hunyady L, Clark AJ (2002) Agonist activated Adrenocorticotropin receptor internalizes via a Clathrin-mediated G protein receptor kinase dependent mechanism. Endocr Res 28:281\u2013289","journal-title":"Endocr Res"},{"key":"343_CR9","doi-asserted-by":"crossref","unstructured":"Bashiardes S, Christodoulou C (2024) Orally administered drugs and their complicated relationship with our gastrointestinal tract. Microorganisms 12","DOI":"10.3390\/microorganisms12020242"},{"key":"343_CR10","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/hmg\/ddi219","volume":"14","author":"KA Beaumont","year":"2005","unstructured":"Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA (2005) Altered cell surface expression of human Mc1r variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 14:2145\u20132154","journal-title":"Hum Mol Genet"},{"key":"343_CR11","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1523-1755.1999.00675.x","volume":"56","author":"AL Berg","year":"1999","unstructured":"Berg AL, Nilsson-Ehle P, Arnadottir M (1999) Beneficial effects of Acth on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 56:1534\u20131543","journal-title":"Kidney Int"},{"key":"343_CR12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2307\/2094863","volume":"42","author":"IN Bernstein","year":"1977","unstructured":"Bernstein IN, Kelly WR, Doyle PA (1977) Societal reaction to deviants: the case of criminal defendants. Am Sociol Rev 42:743\u2013755","journal-title":"Am Sociol Rev"},{"key":"343_CR13","volume":"757","author":"NNA Berruien","year":"2020","unstructured":"Berruien NNA, Smith CL (2020) Emerging roles of Melanocortin receptor accessory proteins (Mrap and Mrap2) in physiology and pathophysiology. Gene 757:144949","journal-title":"Gene"},{"key":"343_CR14","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.156.7.2517","volume":"156","author":"RS Bhardwaj","year":"1996","unstructured":"Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, Luger TA (1996) Pro-opiomelanocortin-derived peptides induce Il-10 production in human monocytes. J Immunol 156:2517\u20132521","journal-title":"J Immunol"},{"key":"343_CR15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12325-022-02332-w","volume":"40","author":"J Bindra","year":"2023","unstructured":"Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio M, Wan GJ (2023) Cost-effectiveness of Acthar gel versus standard of care for the treatment of exacerbations in moderate-to-severe systemic lupus erythematosus. Adv Ther 40:194\u2013210","journal-title":"Adv Ther"},{"key":"343_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bcp.2016.07.003","volume":"116","author":"M Bohm","year":"2016","unstructured":"Bohm M, Apel M, Lowin T, Lorenz J, Jenei-Lanzl Z, Capellino S, Dosoki H, Luger TA, Straub RH, Grassel S (2016) Alpha-Msh modulates cell adhesion and inflammatory responses of synovial fibroblasts from osteoarthritis patients. Biochem Pharmacol 116:89\u201399","journal-title":"Biochem Pharmacol"},{"key":"343_CR17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108862","volume":"34","author":"B Brouwers","year":"2021","unstructured":"Brouwers B, De Oliveira EM, Marti-Solano M, Monteiro FBF, Laurin SA, Keogh JM, Henning E, Bounds R, Daly CA, Houston S, Ayinampudi V, Wasiluk N, Clarke D, Plouffe B, Bouvier M, Babu MM, Farooqi IS, Mokrosinski J (2021) Human Mc4r variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation. Cell Rep 34:108862","journal-title":"Cell Rep"},{"key":"343_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2003.tb03186.x","volume":"994","author":"AA Butler","year":"2003","unstructured":"Butler AA, Cone RD (2003) Knockout studies defining different roles for Melanocortin receptors in energy homeostasis. Ann N Y Acad Sci 994:240\u2013245","journal-title":"Ann N Y Acad Sci"},{"key":"343_CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnins.2017.00128","volume":"11","author":"AA Butler","year":"2017","unstructured":"Butler AA, Girardet C, Mavrikaki M, Trevaskis JL, Macarthur H, Marks DL, Farr SA (2017) A life without hunger: the ups (and downs) to modulating melanocortin-3 receptor signaling. Front Neurosci 11:128","journal-title":"Front Neurosci"},{"key":"343_CR20","volume":"872","author":"VC Can","year":"2020","unstructured":"Can VC, Locke IC, Kaneva MK, Kerrigan MJP, Merlino F, De Pascale C, Grieco P, Getting SJ (2020) Novel anti-inflammatory and chondroprotective effects of the human melanocortin Mc1 receptor agonist Bms-470539 dihydrochloride and human melanocortin Mc3 receptor agonist Pg-990 on lipopolysaccharide activated chondrocytes. Eur J Pharmacol 872:172971","journal-title":"Eur J Pharmacol"},{"key":"343_CR21","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2827","volume":"11","author":"F Capsoni","year":"2009","unstructured":"Capsoni F, Ongari AM, Reali E, Catania A (2009) Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells. Arthritis Res Ther 11:R151","journal-title":"Arthritis Res Ther"},{"key":"343_CR22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1749-6632.1998.tb09622.x","volume":"840","author":"A Catania","year":"1998","unstructured":"Catania A, Airaghi L, Garofalo L, Cutuli M, Lipton JM (1998) The neuropeptide alpha-Msh in Hiv infection and other disorders in humans. Ann N Y Acad Sci 840:848\u2013856","journal-title":"Ann N Y Acad Sci"},{"key":"343_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/clin.1993.1010","volume":"66","author":"A Catania","year":"1993","unstructured":"Catania A, Airaghi L, Manfredi MG, Vivirito MC, Milazzo F, Lipton JM, Zanussi C (1993) Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 66:73\u201379","journal-title":"Clin Immunol Immunopathol"},{"key":"343_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000097183","volume":"1","author":"A Catania","year":"1994","unstructured":"Catania A, Gerloni V, Procaccia S, Airaghi L, Manfredi MG, Lomater C, Grossi L, Lipton JM (1994) The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1:321\u2013328","journal-title":"Neuroimmunomodulation"},{"key":"343_CR25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0361-9230(91)90167-I","volume":"26","author":"A Catania","year":"1991","unstructured":"Catania A, Martin LW, Lipton JM (1991) Dexamethasone facilitates release of the neuropeptide alpha-Msh. Brain Res Bull 26:727\u2013730","journal-title":"Brain Res Bull"},{"key":"343_CR26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0196-9781(96)00037-X","volume":"17","author":"A Catania","year":"1996","unstructured":"Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM (1996) The neuropeptide alpha-Msh has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17:675\u2013679","journal-title":"Peptides"},{"key":"343_CR27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000097087","volume":"1","author":"G Ceriani","year":"1994","unstructured":"Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM (1994) The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1:28\u201332","journal-title":"Neuroimmunomodulation"},{"key":"343_CR28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0196-9781(03)00104-9","volume":"24","author":"BX Chai","year":"2003","unstructured":"Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I (2003) Inverse agonist activity of agouti and agouti-related protein. Peptides 24:603\u2013609","journal-title":"Peptides"},{"key":"343_CR29","doi-asserted-by":"crossref","unstructured":"Cheng PW, Tsai PJ, Tai MH, Bee YS (2021) Therapeutic effect of alpha-Msh in primary cultured orbital fibroblasts obtained from patients with thyroid eye disease. Int J Mol Sci 22","DOI":"10.3390\/ijms222011225"},{"key":"343_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0014-5793(92)80820-7","volume":"309","author":"V Chhajlani","year":"1992","unstructured":"Chhajlani V, Wikberg JE (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor Cdna. FEBS Lett 309:417\u2013420","journal-title":"FEBS Lett"},{"key":"343_CR31","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1172\/JCI118639","volume":"97","author":"H Chiao","year":"1996","unstructured":"Chiao H, Foster S, Thomas R, Lipton J, Star RA (1996) Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 97:2038\u20132044","journal-title":"J Clin Invest"},{"key":"343_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fendo.2016.00101","volume":"7","author":"AJ Clark","year":"2016","unstructured":"Clark AJ, Forfar R, Hussain M, Jerman J, Mciver E, Taylor D, Chan L (2016) Acth antagonists. Front Endocrinol (Lausanne) 7:101","journal-title":"Front Endocrinol (Lausanne)"},{"key":"343_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jlb.67.2.233","volume":"67","author":"M Cutuli","year":"2000","unstructured":"Cutuli M, Cristiani S, Lipton JM, Catania A (2000) Antimicrobial effects of alpha-Msh peptides. J Leukoc Biol 67:233\u2013239","journal-title":"J Leukoc Biol"},{"key":"343_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13075-025-03635-3","volume":"27","author":"CS Davan-Wetton","year":"2025","unstructured":"Davan-Wetton CS, Khodeneva N, Denton CP, Abraham DJ, Perretti M, Montero-Melendez T (2025) The senescence-like activity of Bms-470539 is associated with anti-fibrotic actions in models of dermal fibrosis. Arthritis Res Ther 27:187","journal-title":"Arthritis Res Ther"},{"key":"343_CR35","doi-asserted-by":"crossref","first-page":"E12498","DOI":"10.1371\/journal.pone.0012498","volume":"5","author":"A Delaney","year":"2010","unstructured":"Delaney A, Keighren M, Fleetwood-Walker SM, Jackson IJ (2010) Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin. PLoS One 5:E12498","journal-title":"PLoS One"},{"key":"343_CR36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jlb.63.6.740","volume":"63","author":"R Delgado","year":"1998","unstructured":"Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron P, Lipton JM, Catania A (1998) Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 63:740\u2013745","journal-title":"J Leukoc Biol"},{"key":"343_CR37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685\u20131699","journal-title":"Lancet"},{"key":"343_CR38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","volume":"344","author":"SM Dewire","year":"2013","unstructured":"Dewire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM, Chen XT, Pitis PM, Gotchev D, Yuan C, Koblish M, Lark MW, Violin JD (2013) A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 344:708\u2013717","journal-title":"J Pharmacol Exp Ther"},{"key":"343_CR39","doi-asserted-by":"crossref","first-page":"1083333","DOI":"10.3389\/fimmu.2023.1083333","volume":"14","author":"J Dodd","year":"2023","unstructured":"Dodd J, Jordan R, Makhlina M, Barnett K, Roffel A, Spana C, Obr A, Dhingra P, Kayne PS (2023) A novel oral formulation of the melanocortin-1 receptor agonist Pl8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans. Front Immunol 14:1083333","journal-title":"Front Immunol"},{"key":"343_CR40","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1158\/0008-5472.CAN-09-4596","volume":"70","author":"L Dong","year":"2010","unstructured":"Dong L, Wen J, Pier E, Zhang X, Zhang B, Dong F, Ziegler N, Mysz M, Armenta R, Cui R (2010) Melanocyte-stimulating hormone directly enhances Uv-induced Dna repair in keratinocytes by a Xeroderma Pigmentosum group A-dependent mechanism. Cancer Res 70:3547\u20133556","journal-title":"Cancer Res"},{"key":"343_CR41","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/acs.jmedchem.1c00095","volume":"64","author":"T Durek","year":"2021","unstructured":"Durek T, Kaas Q, White AM, Weidmann J, Fuaad AA, Cheneval O, Schroeder CI, De Veer SJ, Dellsen A, Osterlund T, Larsson N, Knerr L, Bauer U, Plowright AT, Craik DJ (2021) Melanocortin 1 receptor agonists based on a bivalent, bicyclic peptide framework. J Med Chem 64:9906\u20139915","journal-title":"J Med Chem"},{"key":"343_CR42","doi-asserted-by":"crossref","unstructured":"Ericson MD, Freeman KT, Lavoi TM, Donow HM, Santos RG, Giulianotti MA, Pinilla C, Houghten RA, Haskell-Luevano C (2023) The parallel structure-activity relationship screening of three compounds identifies the common agonist pharmacophore of pyrrolidine bis-cyclic guanidine melanocortin-3 receptor (Mc3r) small-molecule ligands. Int J Mol Sci 24","DOI":"10.3390\/ijms241210145"},{"key":"343_CR43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1089\/jop.2023.0056","volume":"39","author":"D Evans","year":"2023","unstructured":"Evans D, Kenyon K, Ousler G, Watson M, Vollmer P, Mclaurin EB, Torkildsen G, Winters J, Dodd J, Jordan R, Wills ST, Spana C (2023) Efficacy and safety of the melanocortin pan-agonist Pl9643 in a phase 2 study of patients with dry eye disease. J Ocul Pharmacol Ther 39:600\u2013610","journal-title":"J Ocul Pharmacol Ther"},{"key":"343_CR44","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.7150\/thno.53083","volume":"11","author":"K Fan","year":"2021","unstructured":"Fan K, Zeng L, Guo J, Xie S, Yu Y, Chen J, Cao J, Xiang Q, Zhang S, Luo Y, Deng Q, Zhou Q, Zhao Y, Hao L, Wang Z, Zhong L (2021) Visualized podocyte-targeting and focused ultrasound responsive glucocorticoid nano-delivery system against immune-associated nephropathy without glucocorticoid side effect. Theranostics 11:2670\u20132690","journal-title":"Theranostics"},{"key":"343_CR45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.mcb.2018.08.005","volume":"149","author":"A Faron-Gorecka","year":"2019","unstructured":"Faron-Gorecka A, Szlachta M, Kolasa M, Solich J, Gorecki A, Kusmider M, Zurawek D, Dziedzicka-Wasylewska M (2019) Understanding Gpcr dimerization. Methods Cell Biol 149:155\u2013178","journal-title":"Methods Cell Biol"},{"key":"343_CR46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","volume":"348","author":"IS Farooqi","year":"2003","unstructured":"Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O\u2019rahilly S (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085\u20131095","journal-title":"N Engl J Med"},{"key":"343_CR47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2018.05.044","volume":"1696","author":"G Feng","year":"2018","unstructured":"Feng G, Feng J, Zhang S, Tong Y, Zhang Q, Yang X, Zhang H (2018) Altered levels of alpha-melanocyte stimulating hormone in cerebrospinal fluid and plasma of patients with traumatic brain injury. Brain Res 1696:22\u201330","journal-title":"Brain Res"},{"key":"343_CR48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1126\/science.271.5247.363","volume":"271","author":"SS Ferguson","year":"1996","unstructured":"Ferguson SS, Downey WE 3rd, Colapietro AM, Barak LS, Menard L, Caron MG (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363\u2013366","journal-title":"Science"},{"key":"343_CR49","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/nn100713m","volume":"4","author":"F Fioretti","year":"2010","unstructured":"Fioretti F, Mendoza-Palomares C, Helms M, Al Alam D, Richert L, Arntz Y, Rinckenbach S, Garnier F, Haikel Y, Gangloff SC, Benkirane-Jessel N (2010) Nanostructured assemblies for dental application. ACS Nano 4:3277\u20133287","journal-title":"ACS Nano"},{"key":"343_CR50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1124\/jpet.103.055525","volume":"307","author":"Z Gao","year":"2003","unstructured":"Gao Z, Lei D, Welch J, Le K, Lin J, Leng S, Duhl D (2003) Agonist-dependent internalization of the human melanocortin-4 receptors in human embryonic kidney 293 cells. J Pharmacol Exp Ther 307:870\u2013877","journal-title":"J Pharmacol Exp Ther"},{"key":"343_CR51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1751-1097.2009.00598.x","volume":"85","author":"G Garcin","year":"2009","unstructured":"Garcin G, Le Gallic L, Stoebner PE, Guezennec A, Guesnet J, Lavabre-Bertrand T, Martinez J, Meunier L (2009) Constitutive expression of Mc1r in Hacat keratinocytes inhibits basal and Uvb-induced Tnf-alpha production. Photochem Photobiol 85:1440\u20131450","journal-title":"Photochem Photobiol"},{"key":"343_CR52","doi-asserted-by":"crossref","first-page":"1078678","DOI":"10.3389\/fimmu.2022.1078678","volume":"13","author":"J Garrido-Mesa","year":"2022","unstructured":"Garrido-Mesa J, Thomas BL, Dodd J, Spana C, Perretti M, Montero-Melendez T (2022) Pro-resolving and anti-arthritic properties of the Mc(1) selective agonist Pl8177. Front Immunol 13:1078678","journal-title":"Front Immunol"},{"key":"343_CR53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.718902","volume":"12","author":"C Gesualdo","year":"2021","unstructured":"Gesualdo C, Balta C, Platania CBM, Trotta MC, Herman H, Gharbia S, Rosu M, Petrillo F, Giunta S, Della Corte A, Grieco P, Bellavita R, Simonelli F, D\u2019amico M, Hermenean A, Rossi S, Bucolo C (2021) Fingolimod and diabetic retinopathy: a drug repurposing study. Front Pharmacol 12:718902","journal-title":"Front Pharmacol"},{"key":"343_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1189\/jlb.69.1.98","volume":"69","author":"SJ Getting","year":"2001","unstructured":"Getting SJ, Allcock GH, Flower R, Perretti M (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 69:98\u2013104","journal-title":"J Leukoc Biol"},{"key":"343_CR55","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","volume":"46","author":"SJ Getting","year":"2002","unstructured":"Getting SJ, Christian HC, Flower RJ, Perretti M (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46:2765\u20132775","journal-title":"Arthritis Rheum"},{"key":"343_CR56","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.162.12.7446","volume":"162","author":"SJ Getting","year":"1999","unstructured":"Getting SJ, Gibbs L, Clark AJ, Flower RJ, Perretti M (1999) Pomc gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162:7446\u20137453","journal-title":"J Immunol"},{"key":"343_CR57","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.pupt.2008.09.004","volume":"21","author":"SJ Getting","year":"2008","unstructured":"Getting SJ, Riffo-Vasquez Y, Pitchford S, Kaneva M, Grieco P, Page CP, Perretti M, Spina D (2008) A role for Mc3r in modulating lung inflammation. Pulm Pharmacol Ther 21:866\u2013873","journal-title":"Pulm Pharmacol Ther"},{"key":"343_CR58","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102738","volume":"20","author":"R Giacomelli","year":"2021","unstructured":"Giacomelli R, Afeltra A, Bartoloni E, Berardicurti O, Bombardieri M, Bortoluzzi A, Carubbi F, Caso F, Cervera R, Ciccia F, Cipriani P, Coloma-Bazan E, Conti F, Costa L, D\u2019angelo S, Distler O, Feist E, Foulquier N, Gabini M, Gerber V, Gerli R, Grembiale RD, Guggino G, Hoxha A, Iagnocco A, Jordan S, Kahaleh B, Lauper K, Liakouli V, Lubrano E, Margiotta D, Naty S, Navarini L, Perosa F, Perricone C, Perricone R, Prete M, Pers JO, Pitzalis C, Priori R, Rivellese F, Ruffatti A, Ruscitti P, Scarpa R, Shoenfeld Y, Triolo G, Tzioufas A (2021) The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and experts\u2019 consensus. Autoimmun Rev 20:102738","journal-title":"Autoimmun Rev"},{"key":"343_CR59","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1021\/acs.jmedchem.1c01295","volume":"65","author":"LE Gimenez","year":"2022","unstructured":"Gimenez LE, Noblin TA, Williams SY, Mullick Bagchi S, Ji RL, Tao YX, Jeppesen CB, Conde-Frieboes KW, Sawyer TK, Grieco P, Cone RD (2022) Demonstration of a common Dphe(7) to Dnal(2\u2032)(7) peptide ligand antagonist switch for Melanocortin-3 and Melanocortin-4 receptors identifies the systematic mischaracterization of the pharmacological properties of Melanocortin peptides. J Med Chem 65:5990\u20136000","journal-title":"J Med Chem"},{"key":"343_CR60","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjp.0707115","volume":"150","author":"D Giuliani","year":"2007","unstructured":"Giuliani D, Mioni C, Bazzani C, Zaffe D, Botticelli AR, Capolongo S, Sabba A, Galantucci M, Iannone A, Grieco P, Novellino E, Colombo G, Tomasi A, Catania A, Guarini S (2007) Selective Melanocortin Mc4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol 150:595\u2013603","journal-title":"Br J Pharmacol"},{"key":"343_CR61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0196-9781(81)80032-0","volume":"2","author":"JR Glyn","year":"1981","unstructured":"Glyn JR, Lipton JM (1981) Hypothermic and antipyretic effects of centrally administered Acth (1-24) and alpha-Melanotropin. Peptides 2:177\u2013187","journal-title":"Peptides"},{"key":"343_CR62","doi-asserted-by":"crossref","unstructured":"Gravina AG, Pellegrino R, Durante T, Palladino G, Imperio G, D\u2019amico G, Trotta MC, Dallio M, Romeo M, D\u2019amico M, Federico A (2023) The melanocortin system in inflammatory bowel diseases: insights into its mechanisms and therapeutic potentials. Cells:12","DOI":"10.3390\/cells12141889"},{"key":"343_CR63","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41591-022-01880-6","volume":"28","author":"JM Guthridge","year":"2022","unstructured":"Guthridge JM, Wagner CA, James JA (2022) The promise of precision medicine in rheumatology. Nat Med 28:1363\u20131371","journal-title":"Nat Med"},{"key":"343_CR64","volume":"16","author":"K Haggerty","year":"2025","unstructured":"Haggerty K, Black J, Abeles R (2025) Resolution of chronic idiopathic Urticaria with setmelanotide in a patient with Bardet-Biedl syndrome: a case report. Obes Pillars 16:100221","journal-title":"Obes Pillars"},{"key":"343_CR65","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/jm960840h","volume":"40","author":"C Haskell-Luevano","year":"1997","unstructured":"Haskell-Luevano C, Hendrata S, North C, Sawyer TK, Hadley ME, Hruby VJ, Dickinson C, Gantz I (1997a) Discovery of prototype Peptidomimetic agonists at the human Melanocortin receptors Mc1r and Mc4r. J Med Chem 40:2133\u20132139","journal-title":"J Med Chem"},{"key":"343_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(01)00234-8","volume":"99","author":"C Haskell-Luevano","year":"2001","unstructured":"Haskell-Luevano C, Monck EK (2001) Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 99:1\u20137","journal-title":"Regul Pept"},{"key":"343_CR67","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1021\/jm990190s","volume":"42","author":"C Haskell-Luevano","year":"1999","unstructured":"Haskell-Luevano C, Rosenquist A, Souers A, Khong KC, Ellman JA, Cone RD (1999) Compounds that activate the mouse melanocortin-1 receptor identified by screening a small molecule library based upon the beta-turn. J Med Chem 42:4380\u20134387","journal-title":"J Med Chem"},{"key":"343_CR68","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm970018t","volume":"40","author":"C Haskell-Luevano","year":"1997","unstructured":"Haskell-Luevano C, Toth K, Boteju L, Job C, Castrucci AM, Hadley ME, Hruby VJ (1997b) Beta-methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity. J Med Chem 40:2740\u20132749","journal-title":"J Med Chem"},{"key":"343_CR69","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/jm025600i","volume":"46","author":"TF Herpin","year":"2003","unstructured":"Herpin TF, Yu G, Carlson KE, Morton GC, Wu X, Kang L, Tuerdi H, Khanna A, Tokarski JS, Lawrence RM, Macor JE (2003) Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. J Med Chem 46:1123\u20131126","journal-title":"J Med Chem"},{"key":"343_CR70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/1043-4666(92)90073-Z","volume":"4","author":"ME Hiltz","year":"1992","unstructured":"Hiltz ME, Catania A, Lipton JM (1992) Alpha-Msh peptides inhibit acute inflammation induced in mice by Ril-1 Beta, Ril-6, Rtnf-alpha and endogenous pyrogen but not that caused by Ltb4, Paf and Ril-8. Cytokine 4:320\u2013328","journal-title":"Cytokine"},{"key":"343_CR71","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1096\/fasebj.3.11.2550304","volume":"3","author":"ME Hiltz","year":"1989","unstructured":"Hiltz ME, Lipton JM (1989) Antiinflammatory activity of a Cooh-terminal fragment of the neuropeptide alpha-Msh. FASEB J 3:2282\u20132284","journal-title":"FASEB J"},{"key":"343_CR72","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1021\/jm0104872","volume":"45","author":"JR Holder","year":"2002","unstructured":"Holder JR, Bauzo RM, Xiang Z, Haskell-Luevano C (2002) Structure-activity relationships of the melanocortin tetrapeptide Ac-His-Dphe-Arg-Trp-Nh(2) at the mouse melanocortin receptors. 1. Modifications at the his position. J Med Chem 45:2801\u20132810","journal-title":"J Med Chem"},{"key":"343_CR73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(03)01322-0","volume":"462","author":"JR Holder","year":"2003","unstructured":"Holder JR, Marques FF, Xiang Z, Bauzo RM, Haskell-Luevano C (2003) Characterization of aliphatic, cyclic, and aromatic N-terminally \u201ccapped\u201d His-D-Phe-Arg-Trp-Nh2 Tetrapeptides at the Melanocortin receptors. Eur J Pharmacol 462:41\u201352","journal-title":"Eur J Pharmacol"},{"key":"343_CR74","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.bbadis.2017.03.001","volume":"1863","author":"H Huang","year":"2017","unstructured":"Huang H, Wang W, Tao YX (2017) Pharmacological chaperones for the misfolded Melanocortin-4 receptor associated with human obesity. Biochim Biophys Acta Mol basis Dis 1863:2496\u20132507","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"343_CR75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4161\/mabs.2.6.13420","volume":"2","author":"CJ Hutchings","year":"2010","unstructured":"Hutchings CJ, Koglin M, Marshall FH (2010) Therapeutic antibodies directed at G protein-coupled receptors. MAbs 2:594\u2013606","journal-title":"MAbs"},{"key":"343_CR76","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<684::AID-JNR9>3.0.CO;2-#","volume":"58","author":"T Ichiyama","year":"1999","unstructured":"Ichiyama T, Campbell IL, Furukawa S, Catania A, Lipton JM (1999a) Autocrine alpha-melanocyte-stimulating hormone inhibits Nf-Kappab activation in human glioma. J Neurosci Res 58:684\u2013689","journal-title":"J Neurosci Res"},{"key":"343_CR77","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0196-9781(00)00300-4","volume":"21","author":"T Ichiyama","year":"2000","unstructured":"Ichiyama T, Okada K, Campbell IL, Furukawa S, Lipton JM (2000) Nf-Kappab activation is inhibited in human pulmonary epithelial cells transfected with alpha-melanocyte-stimulating hormone vector. Peptides 21:1473\u20131477","journal-title":"Peptides"},{"key":"343_CR78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-5728(99)00122-8","volume":"99","author":"T Ichiyama","year":"1999","unstructured":"Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, Lipton JM (1999b) Inhibition of peripheral Nf-Kappab activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol 99:211\u2013217","journal-title":"J Neuroimmunol"},{"key":"343_CR79","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ajpath.2011.07.014","volume":"179","author":"M Itoh","year":"2011","unstructured":"Itoh M, Suganami T, Nakagawa N, Tanaka M, Yamamoto Y, Kamei Y, Terai S, Sakaida I, Ogawa Y (2011) Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic Steatohepatitis. Am J Pathol 179:2454\u20132463","journal-title":"Am J Pathol"},{"key":"343_CR80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-2478(94)90131-7","volume":"41","author":"DS Jessop","year":"1994","unstructured":"Jessop DS, Jukes KE, Lightman SL (1994) Release of alpha-melanocyte-stimulating hormone from rat Splenocytes in vitro is dependent on protein synthesis. Immunol Lett 41:191\u2013194","journal-title":"Immunol Lett"},{"key":"343_CR81","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/jm701303z","volume":"51","author":"CG Joseph","year":"2008","unstructured":"Joseph CG, Wilson KR, Wood MS, Sorenson NB, Phan DV, Xiang Z, Witek RM, Haskell-Luevano C (2008) The 1,4-Benzodiazepine-2,5-Dione small molecule template results in melanocortin receptor agonists with nanomolar potencies. J Med Chem 51:1423\u20131431","journal-title":"J Med Chem"},{"key":"343_CR82","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3389\/fimmu.2019.02312","volume":"10","author":"A Kamermans","year":"2019","unstructured":"Kamermans A, Verhoeven T, Van Het Hof B, Koning JJ, Borghuis L, Witte M, Van Horssen J, De Vries HE, Rijnsburger M (2019) Setmelanotide, a novel, selective melanocortin receptor-4 agonist exerts anti-inflammatory actions in astrocytes and promotes an anti-inflammatory macrophage phenotype. Front Immunol 10:2312","journal-title":"Front Immunol"},{"key":"343_CR83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1189\/jlb.1204748","volume":"80","author":"L Kang","year":"2006","unstructured":"Kang L, Mcintyre KW, Gillooly KM, Yang Y, Haycock J, Roberts S, Khanna A, Herpin TF, Yu G, Wu X, Morton GC, Tuerdi H, Koplowitz B, Walker SG, Wardwell-Swanson J, Macor JE, Lawrence RM, Carlson KE (2006) A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 80:897\u2013904","journal-title":"J Leukoc Biol"},{"key":"343_CR84","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000516282","volume":"34","author":"V Kanti","year":"2021","unstructured":"Kanti V, Puder L, Jahnke I, Krabusch PM, Kottner J, Vogt A, Richter C, Andruck A, Lechner L, Poitou C, Krude H, Gottesdiener K, Clement K, Farooqi IS, Wiegand S, Kuhnen P, Blume-Peytavi U (2021) A melanocortin-4 receptor agonist induces skin and hair pigmentation in patients with monogenic mutations in the leptin-Melanocortin pathway. Skin Pharmacol Physiol 34:307\u2013316","journal-title":"Skin Pharmacol Physiol"},{"key":"343_CR85","doi-asserted-by":"crossref","first-page":"33690","DOI":"10.1074\/jbc.M202939200","volume":"277","author":"M Khaled","year":"2002","unstructured":"Khaled M, Larribere L, Bille K, Aberdam E, Ortonne JP, Ballotti R, Bertolotto C (2002) Glycogen synthase kinase 3beta is activated by camp and plays an active role in the regulation of melanogenesis. J Biol Chem 277:33690\u201333697","journal-title":"J Biol Chem"},{"key":"343_CR86","volume-title":"Adrenocorticotropic hormone (Cosyntropin) stimulation test","author":"S Khare","year":"2025","unstructured":"Khare S, Anjum F (2025) Adrenocorticotropic hormone (Cosyntropin) stimulation test. Statpearls, Treasure Island (Fl)"},{"key":"343_CR87","doi-asserted-by":"crossref","first-page":"1084394","DOI":"10.3389\/fimmu.2022.1084394","volume":"13","author":"N Khodeneva","year":"2022","unstructured":"Khodeneva N, Sugimoto MA, Davan-Wetton CSA, Montero-Melendez T (2022) Melanocortin therapies to resolve fibroblast-mediated diseases. Front Immunol 13:1084394","journal-title":"Front Immunol"},{"key":"343_CR88","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jid.2020.11.034","volume":"141","author":"L Koikov","year":"2021","unstructured":"Koikov L, Starner RJ, Swope VB, Upadhyay P, Hashimoto Y, Freeman KT, Knittel JJ, Haskell-Luevano C, Abdel-Malek ZA (2021) Development of Hmc1r selective small agonists for sunless tanning and prevention of Genotoxicity of Uv in melanocytes. J Invest Dermatol 141:1819\u20131829","journal-title":"J Invest Dermatol"},{"key":"343_CR89","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1016\/j.bmcl.2004.07.046","volume":"14","author":"LN Koikov","year":"2004","unstructured":"Koikov LN, Ebetino FH, Hayes JC, Cross-Doersen D, Knittel JJ (2004) End-capping of the modified Melanocortin Tetrapeptide (P-Cl)Phe-D-Phe-Arg-Trp-Nh2 as a route to Hmc4r agonists. Bioorg Med Chem Lett 14:4839\u20134842","journal-title":"Bioorg Med Chem Lett"},{"key":"343_CR90","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/art.24228","volume":"60","author":"A Kokot","year":"2009","unstructured":"Kokot A, Sindrilaru A, Schiller M, Sunderkotter C, Kerkhoff C, Eckes B, Scharffetter-Kochanek K, Luger TA, Bohm M (2009) Alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma? Arthritis Rheum 60:592\u2013603","journal-title":"Arthritis Rheum"},{"key":"343_CR91","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-022-02899-3","volume":"24","author":"M Kondo","year":"2022","unstructured":"Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, Blyszczuk P, Ross RL, Mulipa P, Del Galdo F, Zhang Y, Distler JHW (2022) Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Arthritis Res Ther 24:210","journal-title":"Arthritis Res Ther"},{"key":"343_CR92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.pharmtox.38.1.289","volume":"38","author":"JG Krupnick","year":"1998","unstructured":"Krupnick JG, Benovic JL (1998) The role of receptor kinases and Arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289\u2013319","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"343_CR93","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.peptides.2009.07.012","volume":"30","author":"KG Kumar","year":"2009","unstructured":"Kumar KG, Sutton GM, Dong JZ, Roubert P, Plas P, Halem HA, Culler MD, Yang H, Dixit VD, Butler AA (2009) Analysis of the therapeutic functions of novel melanocortin receptor agonists in Mc3r- and Mc4r-deficient C57bl\/6j mice. Peptides 30:1892\u20131900","journal-title":"Peptides"},{"key":"343_CR94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41586-021-04088-9","volume":"599","author":"BYH Lam","year":"2021","unstructured":"Lam BYH et al (2021) Mc3r links nutritional state to childhood growth and the timing of puberty. Nature 599:436\u2013441","journal-title":"Nature"},{"key":"343_CR95","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1113\/jphysiol.1905.sp001128","volume":"33","author":"JN Langley","year":"1905","unstructured":"Langley JN (1905) On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to Curari. J Physiol 33:374\u2013413","journal-title":"J Physiol"},{"key":"343_CR96","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/jcem.87.3.8461","volume":"87","author":"YS Lee","year":"2002","unstructured":"Lee YS, Poh LK, Loke KY (2002) A novel melanocortin 3 receptor gene (Mc3r) mutation associated with severe obesity. J Clin Endocrinol Metab 87:1423\u20131426","journal-title":"J Clin Endocrinol Metab"},{"key":"343_CR97","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acschemneuro.6b00399","volume":"8","author":"CJ Lensing","year":"2017","unstructured":"Lensing CJ, Adank DN, Wilber SL, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C (2017) A direct in vivo comparison of the melanocortin monovalent agonist Ac-His-Dphe-Arg-Trp-Nh(2) versus the bivalent agonist Ac-His-Dphe-Arg-Trp-Pedg20-His-Dphe-Arg-Trp-Nh(2): a bivalent advantage. ACS Chem Neurosci 8:1262\u20131278","journal-title":"ACS Chem Neurosci"},{"key":"343_CR98","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1021\/acs.jmedchem.5b01894","volume":"59","author":"CJ Lensing","year":"2016","unstructured":"Lensing CJ, Freeman KT, Schnell SM, Adank DN, Speth RC, Haskell-Luevano C (2016) An in vitro and in vivo investigation of bivalent ligands that display preferential binding and functional activity for different melanocortin receptor homodimers. J Med Chem 59:3112\u20133128","journal-title":"J Med Chem"},{"key":"343_CR99","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/acs.jmedchem.8b00238","volume":"62","author":"CJ Lensing","year":"2019","unstructured":"Lensing CJ, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C (2019) Developing a biased unmatched bivalent ligand (Bumbl) design strategy to target the Gpcr homodimer allosteric signaling (camp over beta-arrestin 2 recruitment) within the melanocortin receptors. J Med Chem 62:144\u2013158","journal-title":"J Med Chem"},{"key":"343_CR100","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1096\/fj.08-113886","volume":"22","author":"G Leoni","year":"2008","unstructured":"Leoni G, Patel HB, Sampaio AL, Gavins FN, Murray JF, Grieco P, Getting SJ, Perretti M (2008) Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J 22:4228\u20134238","journal-title":"FASEB J"},{"key":"343_CR101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1476-5381.2010.00688.x","volume":"160","author":"G Leoni","year":"2010","unstructured":"Leoni G, Voisin MB, Carlson K, Getting S, Nourshargh S, Perretti M (2010) The melanocortin MC(1) receptor agonist Bms-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br J Pharmacol 160:171\u2013180","journal-title":"Br J Pharmacol"},{"key":"343_CR102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1189\/jlb.0707463","volume":"84","author":"D Li","year":"2008","unstructured":"Li D, Taylor AW (2008) Diminishment of alpha-Msh anti-inflammatory activity in Mc1r Sirna-transfected Raw264.7 macrophages. J Leukoc Biol 84:191\u2013198","journal-title":"J Leukoc Biol"},{"key":"343_CR103","doi-asserted-by":"crossref","unstructured":"Li M, Liu D, Lee D, Cheng Y, Baumhover NJ, Marks BM, Sagastume EA, Ballas ZK, Johnson FL, Morris ZS, Schultz MK (2021) Targeted alpha-particle radiotherapy and immune checkpoint inhibitors induces cooperative inhibition on tumor growth of malignant melanoma. Cancers (Basel):13","DOI":"10.3390\/cancers13153676"},{"key":"343_CR104","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000542-200503000-00006","volume":"102","author":"EB Liem","year":"2005","unstructured":"Liem EB, Joiner TV, Tsueda K, Sessler DI (2005) Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology 102:509\u2013514","journal-title":"Anesthesiology"},{"key":"343_CR105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2009101025","volume":"21","author":"A Lindskog","year":"2010","unstructured":"Lindskog A, Ebefors K, Johansson ME, Stefansson B, Granqvist A, Arnadottir M, Berg AL, Nystrom J, Haraldsson B (2010) Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol 21:1290\u20131298","journal-title":"J Am Soc Nephrol"},{"key":"343_CR106","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.14933","volume":"153","author":"R Link","year":"2020","unstructured":"Link R, Veiksina S, Tahk MJ, Laasfeld T, Paiste P, Kopanchuk S, Rinken A (2020) The constitutive activity of melanocortin-4 receptors in camp pathway is allosterically modulated by zinc and copper ions. J Neurochem 153:346\u2013361","journal-title":"J Neurochem"},{"key":"343_CR107","first-page":"137","volume":"741","author":"JM Lipton","year":"1994","unstructured":"Lipton JM, Ceriani G, Macaluso A, Mccoy D, Carnes K, Biltz J, Catania A (1994) Antiinflammatory effects of the neuropeptide alpha-Msh in acute, chronic, and systemic inflammation. Ann N Y Acad Sci 741:137\u2013148","journal-title":"Ann N Y Acad Sci"},{"key":"343_CR108","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0196-9781(91)90135-C","volume":"12","author":"JM Lipton","year":"1991","unstructured":"Lipton JM, Macaluso A, Hiltz ME, Catania A (1991) Central administration of the peptide alpha-Msh inhibits inflammation in the skin. Peptides 12:795\u2013798","journal-title":"Peptides"},{"key":"343_CR109","first-page":"1491","volume":"62","author":"G Liu","year":"2016","unstructured":"Liu G, Chen Y, Wang G, Niu J (2016) Decreased synovial fluid alpha-melanocyte-stimulating-hormone (alpha-Msh) levels reflect disease severity in patients with posttraumatic ankle osteoarthritis. Clin Lab 62:1491\u20131500","journal-title":"Clin Lab"},{"key":"343_CR110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41573-025-01139-y","volume":"24","author":"JS Lorente","year":"2025","unstructured":"Lorente JS, Sokolov AV, Ferguson G, Schioth HB, Hauser AS, Gloriam DE (2025) Gpcr drug discovery: new agents, targets and indications. Nat Rev Drug Discov 24:458\u2013479","journal-title":"Nat Rev Drug Discov"},{"key":"343_CR111","doi-asserted-by":"crossref","first-page":"E105858","DOI":"10.1371\/journal.pone.0105858","volume":"9","author":"J Lorenz","year":"2014","unstructured":"Lorenz J, Seebach E, Hackmayer G, Greth C, Bauer RJ, Kleinschmidt K, Bettenworth D, Bohm M, Grifka J, Grassel S (2014) Melanocortin 1 receptor-signaling deficiency results in an articular cartilage phenotype and accelerates pathogenesis of surgically induced murine osteoarthritis. PLoS One 9:E105858","journal-title":"PLoS One"},{"key":"343_CR112","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2019.03.044","volume":"177","author":"LA Lotta","year":"2019","unstructured":"Lotta LA, Mokrosinski J, Mendes De Oliveira E, Li C, Sharp SJ, Luan J, Brouwers B, Ayinampudi V, Bowker N, Kerrison N, Kaimakis V, Hoult D, Stewart ID, Wheeler E, Day FR, Perry JRB, Langenberg C, Wareham NJ, Farooqi IS (2019) Human gain-of-function Mc4r variants show signaling bias and protect against obesity. Cell 177:597\u2013607","journal-title":"Cell"},{"key":"343_CR113","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/371799a0","volume":"371","author":"D Lu","year":"1994","unstructured":"Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO et al (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371:799\u2013802","journal-title":"Nature"},{"key":"343_CR114","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000097145","volume":"1","author":"K Lyson","year":"1994","unstructured":"Lyson K, Ceriani G, Takashima A, Catania A, Lipton JM (1994) Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells. Neuroimmunomodulation 1:121\u2013126","journal-title":"Neuroimmunomodulation"},{"key":"343_CR115","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/gut.2005.083634","volume":"55","author":"C Maaser","year":"2006","unstructured":"Maaser C, Kannengiesser K, Specht C, Lugering A, Brzoska T, Luger TA, Domschke W, Kucharzik T (2006) Crucial role of the melanocortin receptor Mc1r in experimental colitis. Gut 55:1415\u20131422","journal-title":"Gut"},{"key":"343_CR116","doi-asserted-by":"crossref","unstructured":"Madigan KE, Rudnick SR, Agnew MA, Urooj N, Bonkovsky HL (2023) Illuminating dersimelagon: a novel agent in the treatment of erythropoietic protoporphyria and X-linked protoporphyria. Pharmaceuticals (Basel):17","DOI":"10.20944\/preprints202309.2077.v1"},{"key":"343_CR117","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2004.11.036","volume":"326","author":"I Mandrika","year":"2005","unstructured":"Mandrika I, Petrovska R, Wikberg J (2005) Melanocortin receptors form constitutive homo- and heterodimers. Biochem Biophys Res Commun 326:349\u2013354","journal-title":"Biochem Biophys Res Commun"},{"key":"343_CR118","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.161.6.2873","volume":"161","author":"SK Manna","year":"1998","unstructured":"Manna SK, Aggarwal BB (1998) Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor Nf-kappa B activation induced by various inflammatory agents. J Immunol 161:2873\u20132880","journal-title":"J Immunol"},{"key":"343_CR119","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004563217738802","volume":"55","author":"Z Mao","year":"2018","unstructured":"Mao Z, Liu G, Chen JJ, Liu D, Xu MP, Zhao C, Yang HT, Yue YB (2018) Serum alpha-melanocyte-stimulating hormone may act as a protective biomarker for non-traumatic osteonecrosis of the femoral head. Ann Clin Biochem 55:453\u2013460","journal-title":"Ann Clin Biochem"},{"key":"343_CR120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A (2021) Setmelanotide: first approval. Drugs 81:397\u2013403","journal-title":"Drugs"},{"key":"343_CR121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(91)90015-H","volume":"12","author":"LW Martin","year":"1991","unstructured":"Martin LW, Catania A, Hiltz ME, Lipton JM (1991) Neuropeptide alpha-Msh antagonizes Il-6- and Tnf-induced fever. Peptides 12:297\u2013299","journal-title":"Peptides"},{"key":"343_CR122","first-page":"R768","volume":"259","author":"LW Martin","year":"1990","unstructured":"Martin LW, Lipton JM (1990) Acute phase response to endotoxin: rise in plasma alpha-Msh and effects of alpha-Msh injection. Am J Phys 259:R768\u2013R772","journal-title":"Am J Phys"},{"key":"343_CR123","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41562-023-01528-6","volume":"7","author":"I Mathieson","year":"2023","unstructured":"Mathieson I, Day FR, Barban N, Tropf FC, Brazel DM et al (2023) Genome-wide analysis identifies genetic effects on reproductive success and ongoing natural selection at the FADS locus. Nat Hum Behav 7:790\u2013801","journal-title":"Nat Hum Behav"},{"key":"343_CR124","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1190159","volume":"119","author":"L Mcloughlin","year":"1988","unstructured":"Mcloughlin L, Evans SF, Watson JD, Hinds CJ, Rees LH (1988) Characterization of circulating pro-opiomelanocortin-related peptides in human septic shock. J Endocrinol 119:159\u2013165","journal-title":"J Endocrinol"},{"key":"343_CR125","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1073\/pnas.91.7.2562","volume":"91","author":"EJ Michaud","year":"1994","unstructured":"Michaud EJ, Bultman SJ, Klebig ML, Van Vugt MJ, Stubbs LJ, Russell LB, Woychik RP (1994) A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (ay) mutation. Proc Natl Acad Sci USA 91:2562\u20132566","journal-title":"Proc Natl Acad Sci USA"},{"key":"343_CR126","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1007\/s12325-025-03359-5","volume":"42","author":"M Mirsaeidi","year":"2025","unstructured":"Mirsaeidi M, Kaplan J, Affeldt J, Berkovich R, Askanase A (2025) A narrative review of the immunomodulatory effects of Acthar((R)) gel beyond its steroidogenic properties. Adv Ther 42:5365\u20135379","journal-title":"Adv Ther"},{"key":"343_CR127","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.smim.2015.02.003","volume":"27","author":"T Montero-Melendez","year":"2015","unstructured":"Montero-Melendez T (2015) Acth: the forgotten therapy. Semin Immunol 27:216\u2013226","journal-title":"Semin Immunol"},{"key":"343_CR128","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101603","volume":"59","author":"T Montero-Melendez","year":"2022","unstructured":"Montero-Melendez T, Boesen T, Jonassen TEN (2022) Translational advances of melanocortin drugs: integrating biology, chemistry and genetics. Semin Immunol 59:101603","journal-title":"Semin Immunol"},{"key":"343_CR129","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00018-016-2419-3","volume":"74","author":"T Montero-Melendez","year":"2017","unstructured":"Montero-Melendez T, Forfar RA, Cook JM, Jerman JC, Taylor DL, Perretti M (2017) Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3. Cell Mol Life Sci 74:1335\u20131345","journal-title":"Cell Mol Life Sci"},{"key":"343_CR130","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.1402645","volume":"194","author":"T Montero-Melendez","year":"2015","unstructured":"Montero-Melendez T, Gobbetti T, Cooray SN, Jonassen TE, Perretti M (2015) Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects. J Immunol 194:3381\u20133388","journal-title":"J Immunol"},{"key":"343_CR131","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41467-020-14421-x","volume":"11","author":"T Montero-Melendez","year":"2020","unstructured":"Montero-Melendez T, Nagano A, Chelala C, Filer A, Buckley CD, Perretti M (2020) Therapeutic senescence via Gpcr activation in synovial fibroblasts facilitates resolution of arthritis. Nat Commun 11:745","journal-title":"Nat Commun"},{"key":"343_CR132","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11926-011-0163-0","volume":"13","author":"T Montero-Melendez","year":"2011","unstructured":"Montero-Melendez T, Patel HB, Perretti M (2011a) Role of melanocortin receptors in the regulation of gouty inflammation. Curr Rheumatol Rep 13:138\u2013145","journal-title":"Curr Rheumatol Rep"},{"key":"343_CR133","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ajpath.2011.03.042","volume":"179","author":"T Montero-Melendez","year":"2011","unstructured":"Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M (2011b) The melanocortin agonist Ap214 exerts anti-inflammatory and proresolving properties. Am J Pathol 179:259\u2013269","journal-title":"Am J Pathol"},{"key":"343_CR134","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1126\/science.1325670","volume":"257","author":"KG Mountjoy","year":"1992","unstructured":"Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248\u20131251","journal-title":"Science"},{"key":"343_CR135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1742-7843.2007.00133.x","volume":"101","author":"R Muceniece","year":"2007","unstructured":"Muceniece R, Zvejniece L, Vilskersts R, Liepinsh E, Baumane L, Kalvinsh I, Wikberg JE, Dambrova M (2007) Functional evaluation of Thiq, a melanocortin 4 receptor agonist, in models of food intake and inflammation. Basic Clin Pharmacol Toxicol 101:416\u2013420","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"343_CR136","volume":"218","author":"TF Ng","year":"2022","unstructured":"Ng TF, Dawit K, Taylor AW (2022) Melanocortin receptor agonists suppress experimental autoimmune uveitis. Exp Eye Res 218:108986","journal-title":"Exp Eye Res"},{"key":"343_CR137","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.peptides.2004.12.037","volume":"27","author":"SA Nickolls","year":"2006","unstructured":"Nickolls SA, Maki RA (2006) Dimerization of the melanocortin 4 receptor: a study using bioluminescence resonance energy transfer. Peptides 27:380\u2013387","journal-title":"Peptides"},{"key":"343_CR138","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.intimp.2004.04.011","volume":"4","author":"T Nishida","year":"2004","unstructured":"Nishida T, Miyata S, Itoh Y, Mizuki N, Ohgami K, Shiratori K, Ilieva IB, Ohno S, Taylor AW (2004) Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 4:1059\u20131066","journal-title":"Int Immunopharmacol"},{"key":"343_CR139","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cpdd.1235","volume":"12","author":"K Ogawa","year":"2023","unstructured":"Ogawa K, Ide R, Belongie K, Tsuda M, Kawanishi H, Teng R, Ogasawara A (2023) The oral bioavailability and effect of various gastric conditions on the pharmacokinetics of dersimelagon in healthy adult volunteers. Clin Pharmacol Drug Dev 12:493\u2013501","journal-title":"Clin Pharmacol Drug Dev"},{"key":"343_CR140","first-page":"4835","volume":"24","author":"HB Patel","year":"2010","unstructured":"Patel HB, Bombardieri M, Sampaio AL, D\u2019acquisto F, Gray M, Grieco P, Getting SJ, Pitzalis C, Perretti M (2010) Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB J 24:4835\u20134843","journal-title":"FASEB J"},{"key":"343_CR141","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3389\/fphar.2018.00919","volume":"9","author":"S Patruno","year":"2018","unstructured":"Patruno S, Garrido-Mesa J, Romano M, Perretti M, Montero-Melendez T (2018) Ligand bias and its association with pro-resolving actions of melanocortin drugs. Front Pharmacol 9:919","journal-title":"Front Pharmacol"},{"key":"343_CR142","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00129785-200505010-00005","volume":"5","author":"MA Penny","year":"2005","unstructured":"Penny MA, Mchale D (2005) Pharmacogenomics and the drug discovery pipeline: when should it be implemented? Am J Pharmacogenomics 5:53\u201362","journal-title":"Am J Pharmacogenomics"},{"key":"343_CR143","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","volume":"36","author":"M Perretti","year":"2015","unstructured":"Perretti M, Leroy X, Bland EJ, Montero-Melendez T (2015) Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci 36:737\u2013755","journal-title":"Trends Pharmacol Sci"},{"key":"343_CR144","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100097","volume":"77","author":"M Perretti","year":"2025","unstructured":"Perretti M, Montero-Melendez T (2025) Resolution pharmacology: state-of-the-art and therapeutic landscape. Pharmacol Rev 77:100097","journal-title":"Pharmacol Rev"},{"key":"343_CR145","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0024-3205(82)90362-9","volume":"31","author":"PS Portoghese","year":"1982","unstructured":"Portoghese PS, Ronsisvalle G, Larson DL, Yim CB, Sayre LM, Takemori AE (1982) Opioid agonist and antagonist bivalent ligands as receptor probes. Life Sci 31:1283\u20131286","journal-title":"Life Sci"},{"key":"343_CR146","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1677\/joe.0.1800183","volume":"180","author":"LE Pritchard","year":"2004","unstructured":"Pritchard LE, Armstrong D, Davies N, Oliver RL, Schmitz CA, Brennand JC, Wilkinson GF, White A (2004) Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands. J Endocrinol 180:183\u2013191","journal-title":"J Endocrinol"},{"key":"343_CR147","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-0-387-73657-0_142","volume":"611","author":"B Proneth","year":"2009","unstructured":"Proneth B, Portillo FP, Haskell-Luevano C (2009) A combination of ligand Sar and receptor site-directed mutagenesis reveals requirements for antagonist activity at the melanocortin-3 receptor. Adv Exp Med Biol 611:319\u2013320","journal-title":"Adv Exp Med Biol"},{"key":"343_CR148","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0196-9781(84)90027-5","volume":"5","author":"DB Richards","year":"1984","unstructured":"Richards DB, Lipton JM (1984) Effect of alpha-Msh 11-13 (lysine-Proline-valine) on fever in the rabbit. Peptides 5:815\u2013817","journal-title":"Peptides"},{"key":"343_CR149","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/ATVBAHA.114.305064","volume":"35","author":"P Rinne","year":"2015","unstructured":"Rinne P, Ahola-Olli A, Nuutinen S, Koskinen E, Kaipio K, Eerola K, Juonala M, Kahonen M, Lehtimaki T, Raitakari OT, Savontaus E (2015) Deficiency in melanocortin 1 receptor signaling predisposes to vascular endothelial dysfunction and increased arterial stiffness in mice and humans. Arterioscler Thromb Vasc Biol 35:1678\u20131686","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"343_CR150","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.4049\/jimmunol.140.12.4300","volume":"140","author":"B Robertson","year":"1988","unstructured":"Robertson B, Dostal K, Daynes RA (1988) Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and Il-1-inducible biologic responses. J Immunol 140:4300\u20134307","journal-title":"J Immunol"},{"key":"343_CR151","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00915821","volume":"10","author":"BA Robertson","year":"1986","unstructured":"Robertson BA, Gahring LC, Daynes RA (1986) Neuropeptide regulation of interleukin-1 activities. Capacity of alpha-melanocyte stimulating hormone to inhibit Interleukin-1-inducible responses in vivo and in vitro exhibits target cell selectivity. Inflammation 10:371\u2013385","journal-title":"Inflammation"},{"key":"343_CR152","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00018-014-1800-3","volume":"72","author":"AR Rodrigues","year":"2015","unstructured":"Rodrigues AR, Almeida H, Gouveia AM (2015) Intracellular signaling mechanisms of the melanocortin receptors: current state of the art. Cell Mol Life Sci 72:1331\u20131345","journal-title":"Cell Mol Life Sci"},{"key":"343_CR153","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1210\/me.2004-0227","volume":"19","author":"J Sanchez-Mas","year":"2005","unstructured":"Sanchez-Mas J, Guillo LA, Zanna P, Jimenez-Cervantes C, Garcia-Borron JC (2005) Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors. Mol Endocrinol 19:1035\u20131048","journal-title":"Mol Endocrinol"},{"key":"343_CR154","doi-asserted-by":"crossref","unstructured":"Saram SJ, Thomas MN, Feinberg L, Roberts HW, Ramsden CM, Woronkowicz M, Skopinski P (2025) The immunobiology of dry eye disease: a review of the pathogenesis, regulation and therapeutic implications. Int J Mol Sci 26","DOI":"10.20944\/preprints202509.0035.v1"},{"key":"343_CR155","doi-asserted-by":"crossref","first-page":"21729","DOI":"10.1021\/acs.jmedchem.4c02358","volume":"67","author":"A Sato","year":"2024","unstructured":"Sato A, Morokuma K, Adachi T, Andou J, Miyashiro M, Suzuki T, Kawano Y, Kondo M, Ogasawara A, Ide M, Yamamoto Y (2024) Discovery of Mt-7117 (Dersimelagon phosphoric acid): a novel, potent, selective, and nonpeptidic orally available melanocortin 1 receptor agonist. J Med Chem 67:21729\u201321748","journal-title":"J Med Chem"},{"key":"343_CR156","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tips.2007.06.008","volume":"28","author":"TW Schwartz","year":"2007","unstructured":"Schwartz TW, Holst B (2007) Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol Sci 28:366\u2013373","journal-title":"Trends Pharmacol Sci"},{"key":"343_CR157","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1021\/jm025539h","volume":"45","author":"IK Sebhat","year":"2002","unstructured":"Sebhat IK, Martin WJ, Ye Z, Barakat K, Mosley RT, Johnston DB, Bakshi R, Palucki B, Weinberg DH, Macneil T, Kalyani RN, Tang R, Stearns RA, Miller RR, Tamvakopoulos C, Strack AM, Mcgowan E, Cashen DE, Drisko JE, Hom GJ, Howard AD, Macintyre DE, Van Der Ploeg LH, Patchett AA, Nargund RP (2002) Design and pharmacology of N-[(3r)-1,2,3,4-Tetrahydroisoquinolinium- 3-Ylcarbonyl]-(1r)-1-(4-Chlorobenzyl)- 2-[4-Cyclohexyl-4-(1h-1,2,4-Triazol- 1-Ylmethyl)Piperidin-1-Yl]-2-Oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 45:4589\u20134593","journal-title":"J Med Chem"},{"key":"343_CR158","volume":"12","author":"N Sharfman","year":"2021","unstructured":"Sharfman N, Gilpin NW (2021) The role of melanocortin plasticity in pain-related outcomes after alcohol exposure. Front Psych 12:764720","journal-title":"Front Psych"},{"key":"343_CR159","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1210\/en.2002-220931","volume":"144","author":"H Shinyama","year":"2003","unstructured":"Shinyama H, Masuzaki H, Fang H, Flier JS (2003) Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144:1301\u20131314","journal-title":"Endocrinology"},{"key":"343_CR160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2377-10-73","volume":"10","author":"N Shishioh-Ikejima","year":"2010","unstructured":"Shishioh-Ikejima N, Ogawa T, Yamaguti K, Watanabe Y, Kuratsune H, Kiyama H (2010) The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients. BMC Neurol 10:73","journal-title":"BMC Neurol"},{"key":"343_CR161","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1038\/s41467-025-63988-w","volume":"16","author":"I Sohail","year":"2025","unstructured":"Sohail I, Laurin SA, Kleinau G, Chunilal V, Morton A, Brenlla A, Kagiali ZCU, Blouin MJ, Tello JA, Beck-Sickinger AG, Lohse MJ, Scheerer P, Bouvier M, Mccormick P, Annibale P, Biebermann H (2025) Mrap2 modifies the signaling and oligomerization state of the melanocortin-4 receptor. Nat Commun 16:8324","journal-title":"Nat Commun"},{"key":"343_CR162","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1073\/pnas.92.17.8016","volume":"92","author":"RA Star","year":"1995","unstructured":"Star RA, Rajora N, Huang J, Stock RC, Catania A, Lipton JM (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92:8016\u20138020","journal-title":"Proc Natl Acad Sci USA"},{"key":"343_CR163","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108232","volume":"178","author":"J Starnowska-Sokol","year":"2020","unstructured":"Starnowska-Sokol J, Piotrowska A, Bogacka J, Makuch W, Mika J, Witkowska E, Godlewska M, Osiejuk J, Gatarz S, Misicka A, Przewlocka B (2020) Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain. Neuropharmacology 178:108232","journal-title":"Neuropharmacology"},{"key":"343_CR164","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.2007.13","volume":"39","author":"P Sulem","year":"2007","unstructured":"Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, Manolescu A, Karason A, Palsson A, Thorleifsson G, Jakobsdottir M, Steinberg S, Palsson S, Jonasson F, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Kiemeney LA, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir U, Stefansson K (2007) Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 39:1443\u20131452","journal-title":"Nat Genet"},{"key":"343_CR165","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s44319-024-00109-6","volume":"25","author":"A Suominen","year":"2024","unstructured":"Suominen A, Saldo Rubio G, Ruohonen S, Szabo Z, Pohjolainen L, Ghimire B, Ruohonen ST, Saukkonen K, Ijas J, Skarp S, Kaikkonen L, Cai M, Wardlaw SL, Ruskoaho H, Talman V, Savontaus E, Kerkela R, Rinne P (2024) Alpha-melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor. EMBO Rep 25:1987\u20132014","journal-title":"EMBO Rep"},{"key":"343_CR166","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0021-9258(19)77423-7","volume":"232","author":"EW Sutherland","year":"1958","unstructured":"Sutherland EW, Rall TW (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J Biol Chem 232:1077\u20131091","journal-title":"J Biol Chem"},{"key":"343_CR167","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0021-9258(18)60312-6","volume":"237","author":"EW Sutherland","year":"1962","unstructured":"Sutherland EW, Rall TW, Menon T (1962) Adenyl cylase. I. Distribution, preparation, and properties. J Biol Chem 237:1220\u20131227","journal-title":"J Biol Chem"},{"key":"343_CR168","doi-asserted-by":"crossref","first-page":"11626","DOI":"10.1074\/jbc.REV120.009348","volume":"295","author":"I Sutkeviciute","year":"2020","unstructured":"Sutkeviciute I, Vilardaga JP (2020) Structural insights into emergent signaling modes of G protein-coupled receptors. J Biol Chem 295:11626\u201311642","journal-title":"J Biol Chem"},{"key":"343_CR169","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.jmb.2016.08.002","volume":"428","author":"V Syrovatkina","year":"2016","unstructured":"Syrovatkina V, Alegre KO, Dey R, Huang XY (2016) Regulation, signaling, and physiological functions of G-proteins. J Mol Biol 428:3850\u20133868","journal-title":"J Mol Biol"},{"key":"343_CR170","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1152\/physrev.00029.2016","volume":"98","author":"YX Tao","year":"2018","unstructured":"Tao YX, Conn PM (2018) Pharmacoperones as novel therapeutics for diverse protein conformational diseases. Physiol Rev 98:697\u2013725","journal-title":"Physiol Rev"},{"key":"343_CR171","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3109\/02713689208999545","volume":"11","author":"AW Taylor","year":"1992","unstructured":"Taylor AW, Streilein JW, Cousins SW (1992) Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 11:1199\u20131206","journal-title":"Curr Eye Res"},{"key":"343_CR172","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1749-6632.1999.tb08684.x","volume":"885","author":"P Teofoli","year":"1999","unstructured":"Teofoli P, Frezzolini A, Puddu P, De Pita O, Mauviel A, Lotti T (1999) The role of proopiomelanocortin-derived peptides in skin fibroblast and mast cell functions. Ann N Y Acad Sci 885:268\u2013276","journal-title":"Ann N Y Acad Sci"},{"key":"343_CR173","doi-asserted-by":"crossref","unstructured":"Thapa K, Kadiri JJ, Saukkonen K, Pennanen I, Ghimire B, Cai M, Savontaus E, Rinne P (2023) Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver. elife 12","DOI":"10.7554\/eLife.84782"},{"key":"343_CR174","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1021\/jm0490843","volume":"48","author":"A Todorovic","year":"2005","unstructured":"Todorovic A, Holder JR, Bauzo RM, Scott JW, Kavanagh R, Abdel-Malek Z, Haskell-Luevano C (2005) N-terminal fatty acylated His-Dphe-Arg-Trp-Nh(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes. J Med Chem 48:3328\u20133336","journal-title":"J Med Chem"},{"key":"343_CR175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(92)90738-P","volume":"220","author":"Y Uehara","year":"1992","unstructured":"Uehara Y, Shimizu H, Sato N, Tanaka Y, Shimomura Y, Mori M (1992) Carboxyl-terminal tripeptide of alpha-melanocyte-stimulating hormone antagonizes interleukin-1-induced anorexia. Eur J Pharmacol 220:119\u2013122","journal-title":"Eur J Pharmacol"},{"key":"343_CR176","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/pcmr.13180","volume":"37","author":"PR Upadhyay","year":"2024","unstructured":"Upadhyay PR, Swope VB, Starner RJ, Koikov L, Abdel-Malek ZA (2024) Journey through the spectacular landscape of melanocortin 1 receptor. Pigment Cell Melanoma Res 37:667\u2013680","journal-title":"Pigment Cell Melanoma Res"},{"key":"343_CR177","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","volume":"11","author":"P Valverde","year":"1995","unstructured":"Valverde P, Healy E, Jackson I, Rees JL, Thody AJ (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328\u2013330","journal-title":"Nat Genet"},{"key":"343_CR178","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108918","volume":"274","author":"J Wang","year":"2025","unstructured":"Wang J, Xu F, Liu Y, Zhou H, Yuan W, Liu F, Fang Y, Liang X (2025) Therapeutic exploration of biased ligands at class A G protein-coupled receptors over the past 20 years. Pharmacol Ther 274:108918","journal-title":"Pharmacol Ther"},{"key":"343_CR179","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/JME-14-0005","volume":"53","author":"XH Wang","year":"2014","unstructured":"Wang XH, Wang HM, Zhao BL, Yu P, Fan ZC (2014) Rescue of defective Mc4r cell-surface expression and signaling by a novel Pharmacoperone Ipsen 17. J Mol Endocrinol 53:17\u201329","journal-title":"J Mol Endocrinol"},{"key":"343_CR180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0361-9230(93)90192-E","volume":"32","author":"T Watanabe","year":"1993","unstructured":"Watanabe T, Hiltz ME, Catania A, Lipton JM (1993) Inhibition of Il-1 Beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-Msh. Brain Res Bull 32:311\u2013314","journal-title":"Brain Res Bull"},{"key":"343_CR181","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1210\/me.2009-0283","volume":"24","author":"TR Webb","year":"2010","unstructured":"Webb TR, Clark AJ (2010) Minireview: the melanocortin 2 receptor accessory proteins. Mol Endocrinol 24:475\u2013484","journal-title":"Mol Endocrinol"},{"key":"343_CR182","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jamadermatol.2020.0352","volume":"156","author":"D Wensink","year":"2020","unstructured":"Wensink D, Wagenmakers M, Barman-Aksozen J, Friesema ECH, Wilson JHP, Van Rosmalen J, Langendonk JG (2020) Association of afamelanotide with improved outcomes in patients with erythropoietic protoporphyria in clinical practice. JAMA Dermatol 156:570\u2013575","journal-title":"JAMA Dermatol"},{"key":"343_CR183","volume":"95","author":"CS Wu","year":"2023","unstructured":"Wu CS, Cioanca AV, Gelmi MC, Wen L, Di Girolamo N, Zhu L, Natoli R, Conway RM, Petsoglou C, Jager MJ, Mccluskey PJ, Madigan MC (2023) The multifunctional human ocular melanocortin system. Prog Retin Eye Res 95:101187","journal-title":"Prog Retin Eye Res"},{"key":"343_CR184","doi-asserted-by":"crossref","first-page":"290","DOI":"10.36849\/JDD.5526","volume":"20","author":"J Wu","year":"2021","unstructured":"Wu J, Cotliar R (2021) Afamelanotide: an orphan drug with potential for broad dermatologic applications. J Drugs Dermatol 20:290\u2013294","journal-title":"J Drugs Dermatol"},{"key":"343_CR185","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cns.13789","volume":"28","author":"D Wynn","year":"2022","unstructured":"Wynn D, Goldstick L, Bauer W, Zhao E, Tarau E, Cohen JA, Robertson D, Miller A (2022) Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids. CNS Neurosci Ther 28:364\u2013371","journal-title":"CNS Neurosci Ther"},{"key":"343_CR186","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1007\/s00018-020-03511-0","volume":"77","author":"Y Xu","year":"2020","unstructured":"Xu Y, Guan X, Zhou R, Gong R (2020) Melanocortin 5 receptor signaling pathway in health and disease. Cell Mol Life Sci 77:3831\u20133840","journal-title":"Cell Mol Life Sci"},{"key":"343_CR187","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/mend.11.3.9898","volume":"11","author":"YK Yang","year":"1997","unstructured":"Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, Barsh GS, Gantz I (1997) Effects of recombinant agouti-signaling protein on melanocortin action. Mol Endocrinol 11:274\u2013280","journal-title":"Mol Endocrinol"},{"key":"343_CR188","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12974-021-02078-2","volume":"18","author":"S Yu","year":"2021","unstructured":"Yu S, Doycheva DM, Gamdzyk M, Yang Y, Lenahan C, Li G, Li D, Lian L, Tang J, Lu J, Zhang JH (2021) Activation of Mc1r with Bms-470539 attenuates neuroinflammation via camp\/Pka\/Nurr1 pathway after neonatal hypoxic-ischemic brain injury in rats. J Neuroinflammation 18:26","journal-title":"J Neuroinflammation"},{"key":"343_CR189","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1038\/s41598-020-64305-9","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Chery S, Lazerson A, Altman NH, Jackson R, Holt G, Campos M, Schally AV, Mirsaeidi M (2020) Anti-inflammatory effects of alpha-Msh through P-Creb expression in sarcoidosis like granuloma model. Sci Rep 10:7277","journal-title":"Sci Rep"},{"key":"343_CR190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S (2024) G protein-coupled receptors (Gpcrs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther 9:88","journal-title":"Signal Transduct Target Ther"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2026_343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:14:41Z","timestamp":1779106481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2026_343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":190,"URL":"https:\/\/doi.org\/10.1007\/82_2026_343","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"19 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declares the following as potential competing interests.Trinidad Montero-Melendez has previously received research funding and conducted consultancy for SynAct Pharma ApS. All other authors declare no conflicts of interest. This chapter is a review of previously published accounts; as such, no human or animal studies were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}